Predicting outcome in melanoma: where are we now?

Area of Science:

• Oncology
• Dermatology
• Medical Diagnostics

Background:

• Rising global melanoma incidence poses a significant public health concern.
• High mortality rates in younger populations underscore the need for improved management.
• Current melanoma staging lacks precision in predicting metastatic disease, relapse, and treatment failure.

Purpose of the Study:

• To comprehensively review traditional and emerging melanoma staging methods.
• To evaluate the impact of current and novel staging techniques on patient prognosis.
• To identify advancements in melanoma staging over the last five years.

Main Methods:

• Systematic literature review focusing on research from the past five years.
• Analysis of traditional melanoma staging criteria.
• Evaluation of emerging diagnostic and prognostic tools for melanoma.

Main Results:

• Traditional staging methods show limitations in predicting melanoma progression.
• Emerging novel staging methods demonstrate potential for improved accuracy.
• Recent advancements offer new insights into melanoma risk stratification.

Conclusions:

• Accurate melanoma staging is crucial for effective patient management and improved survival.
• Novel staging approaches are essential to address the limitations of current tools.
• Further research into advanced melanoma staging will enhance prognostic capabilities.